GALAPAGOS NV (GLPG.AS) Fundamental Analysis & Valuation
AMS:GLPG • BE0003818359
Current stock price
27.62 EUR
-0.1 (-0.36%)
Last:
This GLPG.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GLPG.AS Profitability Analysis
1.1 Basic Checks
- In the past year GLPG was profitable.
- GLPG had a negative operating cash flow in the past year.
- In multiple years GLPG reported negative net income over the last 5 years.
- GLPG had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- GLPG has a Return On Assets of 9.42%. This is amongst the best in the industry. GLPG outperforms 84.34% of its industry peers.
- The Return On Equity of GLPG (9.92%) is better than 79.52% of its industry peers.
- GLPG's Return On Invested Capital of 12.06% is amongst the best of the industry. GLPG outperforms 84.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.42% | ||
| ROE | 9.92% | ||
| ROIC | 12.06% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 28.85%, GLPG belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
- Looking at the Operating Margin, with a value of 47.04%, GLPG belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
- The Gross Margin of GLPG (97.33%) is better than 93.98% of its industry peers.
- GLPG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 47.04% | ||
| PM (TTM) | 28.85% | ||
| GM | 97.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5YN/A
2. GLPG.AS Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GLPG is creating some value.
- GLPG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- GLPG has an Altman-Z score of 8.37. This indicates that GLPG is financially healthy and has little risk of bankruptcy at the moment.
- GLPG has a Altman-Z score of 8.37. This is amongst the best in the industry. GLPG outperforms 84.34% of its industry peers.
- A Debt/Equity ratio of 0.00 indicates that GLPG is not too dependend on debt financing.
- With an excellent Debt to Equity ratio value of 0.00, GLPG belongs to the best of the industry, outperforming 92.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 8.37 |
ROIC/WACC1.51
WACC7.99%
2.3 Liquidity
- A Current Ratio of 20.15 indicates that GLPG has no problem at all paying its short term obligations.
- The Current ratio of GLPG (20.15) is better than 98.80% of its industry peers.
- GLPG has a Quick Ratio of 20.00. This indicates that GLPG is financially healthy and has no problem in meeting its short term obligations.
- GLPG has a Quick ratio of 20.00. This is amongst the best in the industry. GLPG outperforms 98.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 20.15 | ||
| Quick Ratio | 20 |
3. GLPG.AS Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 334.82% over the past year.
- The Revenue has grown by 280.53% in the past year. This is a very strong growth!
- The Revenue has been growing by 15.97% on average over the past years. This is quite good.
EPS 1Y (TTM)334.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3023.68%
Revenue 1Y (TTM)280.53%
Revenue growth 3Y58.87%
Revenue growth 5Y15.97%
Sales Q2Q%1093.16%
3.2 Future
- GLPG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.10% yearly.
- The Revenue is expected to decrease by -30.71% on average over the next years. This is quite bad
EPS Next Y-150.44%
EPS Next 2Y-64.81%
EPS Next 3Y-30.23%
EPS Next 5Y-23.1%
Revenue Next Year-0.05%
Revenue Next 2Y-2.62%
Revenue Next 3Y-0.5%
Revenue Next 5Y-30.71%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. GLPG.AS Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 5.67, which indicates a rather cheap valuation of GLPG.
- Compared to the rest of the industry, the Price/Earnings ratio of GLPG indicates a rather cheap valuation: GLPG is cheaper than 96.39% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of GLPG to the average of the S&P500 Index (25.70), we can say GLPG is valued rather cheaply.
- GLPG is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.67 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as GLPG's earnings are expected to decrease with -30.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-64.81%
EPS Next 3Y-30.23%
5. GLPG.AS Dividend Analysis
5.1 Amount
- No dividends for GLPG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GLPG.AS Fundamentals: All Metrics, Ratios and Statistics
AMS:GLPG (3/13/2026, 7:00:00 PM)
27.62
-0.1 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-24 2026-02-24/bmo
Earnings (Next)N/A N/A
Inst Owners25.24%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.82B
Revenue(TTM)1.11B
Net Income(TTM)320.88M
Analysts52.22
Price Target31.14 (12.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9817.73%
Min EPS beat(2)-19965.4%
Max EPS beat(2)329.9%
EPS beat(4)1
Avg EPS beat(4)-5598.11%
Min EPS beat(4)-19965.4%
Max EPS beat(4)329.9%
EPS beat(8)4
Avg EPS beat(8)-2634.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)487.53%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)977.92%
Revenue beat(4)2
Avg Revenue beat(4)242.29%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)977.92%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-36.8%
EPS NY rev (3m)-34.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.5%
Revenue NY rev (3m)-0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.67 | ||
| Fwd PE | N/A | ||
| P/S | 1.64 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.56 | ||
| P/tB | 0.56 | ||
| EV/EBITDA | N/A |
EPS(TTM)4.87
EY17.63%
EPS(NY)-2.46
Fwd EYN/A
FCF(TTM)-4.12
FCFYN/A
OCF(TTM)-3.91
OCFYN/A
SpS16.88
BVpS49.1
TBVpS49.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number73.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.42% | ||
| ROE | 9.92% | ||
| ROCE | 16.08% | ||
| ROIC | 12.06% | ||
| ROICexc | 153.5% | ||
| ROICexgc | 154.01% | ||
| OM | 47.04% | ||
| PM (TTM) | 28.85% | ||
| GM | 97.33% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5YN/A
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 1.25% | ||
| Interest Coverage | 1127.48 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 20.15 | ||
| Quick Ratio | 20 | ||
| Altman-Z | 8.37 |
F-Score6
WACC7.99%
ROIC/WACC1.51
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.02%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)334.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3023.68%
EPS Next Y-150.44%
EPS Next 2Y-64.81%
EPS Next 3Y-30.23%
EPS Next 5Y-23.1%
Revenue 1Y (TTM)280.53%
Revenue growth 3Y58.87%
Revenue growth 5Y15.97%
Sales Q2Q%1093.16%
Revenue Next Year-0.05%
Revenue Next 2Y-2.62%
Revenue Next 3Y-0.5%
Revenue Next 5Y-30.71%
EBIT growth 1Y377.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.73%
EBIT Next 3Y21.58%
EBIT Next 5Y15%
FCF growth 1Y32.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.55%
OCF growth 3YN/A
OCF growth 5YN/A
GALAPAGOS NV / GLPG.AS Fundamental Analysis FAQ
What is the fundamental rating for GLPG stock?
ChartMill assigns a fundamental rating of 5 / 10 to GLPG.AS.
Can you provide the valuation status for GALAPAGOS NV?
ChartMill assigns a valuation rating of 2 / 10 to GALAPAGOS NV (GLPG.AS). This can be considered as Overvalued.
What is the profitability of GLPG stock?
GALAPAGOS NV (GLPG.AS) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for GLPG stock?
The Price/Earnings (PE) ratio for GALAPAGOS NV (GLPG.AS) is 5.67 and the Price/Book (PB) ratio is 0.56.